US Patent 11767323 Tricyclic pyridone compounds as JAK2 V617F inhibitors
Patent 11767323 was granted and assigned to Incyte on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+39 properties)
Article (+206 characters)
US Patent 11767323 Tricyclic pyridone compounds as JAK2 V617F inhibitors
Article
Patent abstract
The present application provides tricyclic pyridone compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew W. Buesking
Cheng-Tsung Lai
Jun Pan
Kai Liu
Leah C. Konkol
Liangxing Wu
Onur Atasoylu
Song Mei
Wenqing Yao
Yu Bai
Date of Patent
September 26, 2023
Patent Application Number
17365686
Date Filed
July 1, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11767323 Tricyclic pyridone compounds as JAK2 V617F inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
